Mignani, FR
Gérard Mignani, Lyon FR
Patent application number | Description | Published |
---|---|---|
20100012623 | DELAMINATING SHAPED ARTICLE SUBSTRATES HAVING SILICONE COVERINGS ADHERED THERETO - Shaped article substrates, e.g., plastics, textiles, extrudates, films, etc., having silicone material coverings adhered thereto, are delaminated by treating same with an aqueous solution containing an alkali metal or alkaline earth metal hydroxide and a phase transfer catalyst; particular such shaped article substrates are airbag type of inflatable protection bags having layers of silicone elastomer adhered thereto and used for the protection of the occupants of a motor vehicle. | 01-21-2010 |
20100022789 | Catalytic compositions for the metathesis of unsaturated fatty bodies with olefins and metathesis methods using catalytic compositions - Catalytic compositions useful for carrying out the metathesis of unsaturated fatty bodies, in particular unsaturated fatty bodies comprising oleic acid or oleic acid esters, contain a ruthenium-based catalyst which can be isolated and which has the formula (I) below: | 01-28-2010 |
20100113791 | PREPARATION OF PRECURSORS OF CARBENES OF CAAC TYPE AND PREPARING SAID CARBENES THEREFROM - Precursors of carbenes of CAAC type (Cyclic)(Alkyl)(Amino)(Carbenes) are prepared and carbenes are produced therefrom; novel synthesis intermediates are provided for preparing the precursors of CAAC-type carbenes. | 05-06-2010 |
20100140541 | PREPARATION OF FUNCTIONALIZED, IN PARTICULAR ALKENYLATED, ORGANOMONOALKOXY-(OR MONOHYDROXY)-SILANES - Functionalized organomonoalkoxy (or monohydroxy) silanes, in particular alkenyl (allyl) functionalized silanes, are useful as intermediates in organic synthesis, and are prepared by reacting dialkyldialkoxysilanes with an organic halide compound (allyl halide) (III) in an ether solvent (SI), such compound (III) being suited to substitute the alkoxy groups by functionalized groups, for example alkenyl groups. | 06-10-2010 |
20100144959 | PREPARATION OF ALKOXY- AND/OR HALOSILANE (POLY)SULFIDES AND COUPLING AGENTS COMPRISED THEREOF - At least one (poly)thio alkoxy and/or halosilane is/are prepared by reaction of at least one sulfur-containing reagent with at least one alkoxy and/or halosilane, wherein an ionic addition of a sulfur-containing reagent to an alkoxy and/or halosilane is preferably conducted with thermal and/or actinic activation; the novel polythio alkoxy and/or halosilanes of formula (III.2) thus prepared are particularly useful as coupling agents in elastomeric compositions containing a white filler of the silica type and having the formula (III.2) wherein, for example, R | 06-10-2010 |
20100145089 | PREPARATION OF (POLY)SULFIDE ALKOXYSILANES AND NOVEL INTERMEDIATES THEREFOR - At least one polythio alkoxy and/or halosilane is/are prepared by reacting at least one sulfur-containing reagent (Rs) with at least one alkoxy and/or halosilane; intermediates therefor include the thio alkoxy and/or halosilanes of formula | 06-10-2010 |
20110162525 | TREATMENT OF GASES TO REDUCE THE CARBON DIOXIDE CONTENTS THEREOF - A method for processing a CO | 07-07-2011 |
20110293498 | METHOD FOR TREATING A GAS TO REDUCE THE CARBON DIOXIDE CONTENT THEREOF - The invention relates to a method for reducing the CO | 12-01-2011 |
Serge Mignani, Chatenay-Malabry FR
Serge Mignani, Paris FR
Patent application number | Description | Published |
---|---|---|
20110178053 | AZACARBOLINE DERIVATIVES, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME - The invention relates to novel azacarbonlines having formula (I), wherein: R3, R4 represent independently H; hal; CF | 07-21-2011 |
20120208809 | 9H-PYRROLO[2,3-B: 5,4-C'] DIPYRIDINE AZACARBOLINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF - The invention relates to novel 9H-pyrrolo[2,3-b:5,4-c′]dipyridine azacarbolines of formula (I), where: Z2, Z3, and Z4 are CH, CRa, CRs, or N; R3 is H, Hal; CF3, CHF2; OH, alkoxy; NH2, NH (alkyl), N(alkyl)2; C(O)O alkyl; CONH(alkyl), CON(alkyl)2; C1-C10 alkyl; aryl; heteroaryl; R6 is heteroaryl; Ra is CONH2, CONH alkyl, CONH cycloalkyl; CONH heterocycloalkyl; CON(alkyl)2; CON(alkyl)(heterocycloalkyl); CONHN(alkyl)2; C(O)heterocycloalkyl; Rs is H; Hal, OH; O-alkyl(C1-C10); NH2; N(alkyl(C1-C10) or cycloalkyl(C3-C7))2; NHC(O)R3a; N(alkyl(C1-C10)C(O)R3a; NHS(O2)R3a; N(alkyl)(C1-C10)S(O2)R3a; CO2R3a; SR3a; S(O)R3a; S(O2)R3a; Ra and Rs optionally form a cycle; R3a is selected from among Hal, CF3, C1-C10 alkyl; C3-C7 cycloalkyl; C2-C6 alkenyl; C2-C6 alkynyl; OH; O-alkyl(C1-C10); (C3-C7); heterocycloalkyl (C3-C7); NH2; NH-(alkyl(C1-C10) or cycloalkyl(C3-C7)); N(alkyl(C1-C10) or cycloalkyl(C3-C7))2; NH-(alkyl(C1-C10) or heterocycloalkyl(C3-C7)); N(alkyl(C1-C10) or heterocycloalkyl(C3-C7))2, as well as to the isomers and salts of said substances of formula (I) and to the therapeutic use thereof for treating cancer. | 08-16-2012 |